Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Continuous Glucose Monitoring in Haemodialysis and Peritoneal Dialysis Patients With Type 1 and Type 2 Diabetes

NCT06641765 is registered in ClinicalTrials.gov with Bo Feldt-Rasmussen as lead sponsor.

NCT NCT06641765
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06641765 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Continuous Glucose Monitoring in Haemodialysis and Peritoneal Dialysis Patients With Type 1 and Type 2 Diabetes
Lead sponsor
Bo Feldt-Rasmussen
Phase
Not applicable
Overall status
Active, not recruiting
Start date
November 1, 2024
Completion date
October 30, 2026
Enrollment
96 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

continuous glucose monitoring, diabetes mellitus, type 1, diabetes mellitus, type 2, haemodialysis, peritoneal dialysis